Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nianxin Zhou

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
A Novel Autocrine CXCL14/ACKR2 Axis: The Achilles' Heel of Cancer Metastasis?Qian Zhang, Nianxin Zhou, Wei Wang, et al.
Trends in Cancer|December 20, 2020
Targeting Nuclear Receptors for Cancer Therapy: Premises, Promises, and ChallengesZhengnan Yang, Ryan C Gimple, Nianxin Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2021
OCaMIR-A Noninvasive, Diagnostic Signature for Early-Stage Ovarian Cancer: A Multi-cohort Retrospective and Prospective StudyRaju Kandimalla, Wei Wang, Fan Yu, et al.
Cancer Discovery|April 7, 2026
Correcting Mitochondrial Complex I Defect in Tumor-Associated Natural Killer Cells Potentiates Immunotherapy for GlioblastomaNianxin Zhou, Fan Fei, Lin Tang, et al.
Molecular Cancer|August 2, 2018
Epigenetics in ovarian cancer: premise, properties, and perspectivesQilian Yang, Yuqing Yang, Nianxin Zhou, et al.
Iscience|August 31, 2020
Pharmacological Activation of Estrogen Receptor Beta Overcomes Tumor Resistance to Immune Checkpoint Blockade TherapyShuang Huang, Nianxin Zhou, Linjie Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2018
Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasisLinjie Zhao, Shuang Huang, Shenglin Mei, et al.
Genome Biology|March 18, 2018
The RNA binding protein SORBS2 suppresses metastatic colonization of ovarian cancer by stabilizing tumor-suppressive immunomodulatory transcriptsLinjie Zhao, Wei Wang, Shuang Huang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
A Novel Autocrine CXCL14/ACKR2 Axis: The Achilles' Heel of Cancer Metastasis?Qian Zhang, Nianxin Zhou, Wei Wang, et al.
Trends in Cancer|December 20, 2020
Targeting Nuclear Receptors for Cancer Therapy: Premises, Promises, and ChallengesZhengnan Yang, Ryan C Gimple, Nianxin Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2021
OCaMIR-A Noninvasive, Diagnostic Signature for Early-Stage Ovarian Cancer: A Multi-cohort Retrospective and Prospective StudyRaju Kandimalla, Wei Wang, Fan Yu, et al.
Cancer Discovery|April 7, 2026
Correcting Mitochondrial Complex I Defect in Tumor-Associated Natural Killer Cells Potentiates Immunotherapy for GlioblastomaNianxin Zhou, Fan Fei, Lin Tang, et al.
Molecular Cancer|August 2, 2018
Epigenetics in ovarian cancer: premise, properties, and perspectivesQilian Yang, Yuqing Yang, Nianxin Zhou, et al.
Iscience|August 31, 2020
Pharmacological Activation of Estrogen Receptor Beta Overcomes Tumor Resistance to Immune Checkpoint Blockade TherapyShuang Huang, Nianxin Zhou, Linjie Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2018
Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasisLinjie Zhao, Shuang Huang, Shenglin Mei, et al.
Genome Biology|March 18, 2018
The RNA binding protein SORBS2 suppresses metastatic colonization of ovarian cancer by stabilizing tumor-suppressive immunomodulatory transcriptsLinjie Zhao, Wei Wang, Shuang Huang, et al.
Pageof 1